Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in PCSA — Processa Pharmaceuticals, Inc.

CIK 1214717 BOSTON, MA
Back to PCSA Full portfolio

Position in PCSA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$42,412
-$20,479 QoQ
Shares Held
22,090
-11.3% QoQ
Ownership
0.791%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 12 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. PCSA ranks #483 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in PCSA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $42,412 22,090
2026-03-31 $62,891 24,908
2025-12-31 $44,130 15,323
2025-09-30 $58,234 303,304
2025-06-30 $10,367 50,573
2025-03-31 $12,732 34,413
2024-12-31 $19,431 21,982
2024-09-30 $26,978 19,693
2024-06-30 $38,610 17,237
2023-12-31 $40,881 122,033
2023-09-30 $38,167 152,670
2023-06-30 $34,275 68,827
2023-03-31 $34,413 68,827
2022-12-31 $75,709 68,827
2022-09-30 $146,678 64,902
2022-06-30 $182,374 64,902
2022-03-31 $195,355 64,902
2021-12-31 $318,019 64,902
2021-09-30 $556,210 64,902
2021-06-30 $306,306 37,400
2021-03-31 $303,292 27,825